MSN’s US Entresto Generic Blocked In Part For Being Too Similar To The Brand

A US federal district court in New Jersey has issued a preliminary injunction on the balance of the merits against MSN Laboratories’ “strikingly similar” ‘Novadoz’ generic version of Novartis’ Entresto (sacubitril/valsartan), telling the Indian firm in Novartis’ trademark and trade dress rights infringement suit that it “could have distinguished its pills.”

Granting a preliminary injunction against MSN on the basis of Novartis’ trade dress charge, judge Evelyn Padin was less convinced...